Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.
Gielis S, Flumens D, van der Heijden S, Versteven M, De Reu H, Bartholomeus E, Schippers J, Campillo-Davo D, Berneman ZN, Anguille S, Smits E, Ogunjimi B, Lion E, Laukens K, Meysman P. Gielis S, et al. Among authors: flumens d. Ann Hematol. 2024 Sep 11. doi: 10.1007/s00277-024-05919-1. Online ahead of print. Ann Hematol. 2024. PMID: 39259326
In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.
van der Heijden S, Flumens D, Versteven M, Peeters S, Reu H, Campillo-Davo D, Willemen Y, Ogunjimi B, Van Tendeloo V, Berneman ZN, Anguille S, Smits E, Lion E. van der Heijden S, et al. Among authors: flumens d. STAR Protoc. 2023 Mar 17;4(1):102053. doi: 10.1016/j.xpro.2023.102053. Epub 2023 Jan 30. STAR Protoc. 2023. PMID: 36853720 Free PMC article.
Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands.
Versteven M, Flumens D, Campillo-Davó D, De Reu H, Van Bruggen L, Peeters S, Van Tendeloo V, Berneman Z, Dolstra H, Anguille S, Hobo W, Smits E, Lion E. Versteven M, et al. Among authors: flumens d. Front Immunol. 2022 Feb 17;13:734256. doi: 10.3389/fimmu.2022.734256. eCollection 2022. Front Immunol. 2022. PMID: 35250967 Free PMC article.
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Roex G, Timmers M, Wouters K, Campillo-Davo D, Flumens D, Schroyens W, Chu Y, Berneman ZN, Lion E, Luo F, Anguille S. Roex G, et al. Among authors: flumens d. J Hematol Oncol. 2020 Dec 3;13(1):164. doi: 10.1186/s13045-020-01001-1. J Hematol Oncol. 2020. PMID: 33272302 Free PMC article.